Multi-Institutional Registry for Prostate Cancer Radiosurgery (RPCR)

This study is currently recruiting participants.
Verified March 2013 by Florida Robotic Radiosurgery Association
Sponsor:
Information provided by (Responsible Party):
Florida Robotic Radiosurgery Association
ClinicalTrials.gov Identifier:
NCT01226004
First received: October 20, 2010
Last updated: March 28, 2013
Last verified: March 2013
  Purpose

To address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including prostate specific antigen (PSA), international prostate symptom score (IPSS),sexual health in men (SHIM), and visual analogue scale (VAS) scores, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries, FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data, requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.


Condition
Prostate Cancer Early Risk Treated by Radiosurgery
Prostate Cancer Intermediate Risk Treated by Radiosurgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Multi-Institutional Registry for Prostate Cancer Radiosurgery. An IRB Approved Observational Trial

Resource links provided by NLM:


Further study details as provided by Florida Robotic Radiosurgery Association:

Primary Outcome Measures:
  • Overall survival [ Time Frame: three years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Treatment Outcomes [ Time Frame: Three years ] [ Designated as safety issue: No ]
    Measurement of surrogate outcomes including IPSS and SHIM scores

  • Treatment toxicity [ Time Frame: 3 years ] [ Designated as safety issue: No ]
    urinary and rectal complications as well as sexual health

  • Assess biochemical disease free survival using PSA [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: July 2010
Estimated Study Completion Date: July 2015
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Detailed Description:

To address pertinent questions regarding the utilization of radiosurgery (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT.

The registry is designed to track surrogate treatment endpoints including PSA, IPSS, SHIM, QOL, Karnofsky Performance Status, VAS scores, urine and bowel health, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries.

FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Men over 18 who have early or intermediate risk prostate cancer and have chosen to undergo radiosurgical treatment

Criteria

Inclusion Criteria:

  • pathological diagnosis of prostate cancer
  • early or intermediate risk

Exclusion Criteria:

  • high risk prostate cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01226004

Contacts
Contact: Mark L Perman, MD 772-403-2390 permanmark@gmail.com

Locations
United States, California
Newport Diagnostic Center Recruiting
Newport Beach, California, United States, 92660
Contact: Amanda Schwer, MD     800-605-5170        
Principal Investigator: Amanda Schwer, MD            
Pasadena CyberKnife Center Recruiting
Pasadena, California, United States, 91105
Contact: N Chu            
Principal Investigator: Albert Mak, MD            
CyberKnife of Southern California at Vista Recruiting
Vista, California, United States, 92081
Contact: Patrick Linson, MD     888-542-9237        
Principal Investigator: Patrick Linson, MD            
United States, Colorado
Rocky Mountain CyberKnife Recruiting
Boulder, Colorado, United States, 80304
Contact: J Horsely     303-448-4620     JHorsley@usradiosurgery.com    
Principal Investigator: Lee McNeely, M.D.            
Penrose Cancer Center Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Barry T. Switzer     719-776-5281     BarrySwitzer@centura.org    
Principal Investigator: Anuj Peddada, M.D.            
Denver CyberKnife Recruiting
Denver, Colorado, United States, 80124
Contact: Gregg Dickerson, MD     303-396-1414        
Principal Investigator: Greg Dickerson, MD            
Colorado CyberKnife Recruiting
Lafayette, Colorado, United States, 80026
Contact: C. K. Simpson, MD     303-926-9800     kelley.simpson@coloradocyberknife.com    
Principal Investigator: C. K. Simpson, MD            
United States, District of Columbia
Georgetown University Recruiting
Washington, District of Columbia, United States, 20007
Contact: Sean P Collins, MD, PhD     202-444-3062     spc9@gunet.georgetown.edu    
Principal Investigator: Sean P Collins, MD, PhD            
United States, Florida
JFK Hospital Recruiting
Atlantis, Florida, United States, 33462
Contact: Jamie Kosik     561-965-7300        
Principal Investigator: George Hatoum, M.D.            
CyberKnife Centers of Tampa Bay at Brandon Recruiting
Brandon, Florida, United States, 33511
Contact: Debra Freeman, MD     813-844-6868        
Principal Investigator: Debra Freeman, MD            
North Broward Medical Center Recruiting
Deerfield Beach, Florida, United States, 33064
Contact: Amanda Haerry     954-941-8300        
Coastal CyberKnife Recruiting
Ft. Pierce, Florida, United States, 34982
Contact: Scott Allen     772-293-0377        
Principal Investigator: William Crook, MD            
Cancer Care Centers of Brevard Recruiting
Melbourne, Florida, United States, 32901
Contact: Carolyn Hall     321-951-9991        
Principal Investigator: Silas Charles, MD            
CyberKnife Center of Miami Recruiting
Miami, Florida, United States, 33156
Contact: Gail Suarez     800-204-0455        
Principal Investigator: James Schwade, MD            
University of Miami/Sylvester Cancer Center Recruiting
Miami, Florida, United States, 33136
Contact: A Reyes     305-243-4320        
Principal Investigator: Mathew Abramowitz, MD            
CyberKnife Institute at Mercy Hospital Recruiting
Miami, Florida, United States, 33133
Contact: K Jenkins         KJenkins@mercymiami.org    
Principal Investigator: Raul Ravelo, MD            
CyberKnife Center of Palm Beach Recruiting
Palm Beach Gardens, Florida, United States, 33410
Contact: Gail Suarez     800-204-0455        
Principal Investigator: James Schwade, MD            
Memorial Cancer Institute CyberKnife Center Not yet recruiting
Pembroke Pines, Florida, United States, 33028
Contact: S Sundararaman, MD     954-844-6868        
Principal Investigator: Srinath Sundararaman, MD            
CyberKnife Center of South Florida in Stuart Recruiting
Stuart, Florida, United States, 33996
Contact: Mark Perman, MD     772-403-2390        
Principal Investigator: Mark Perman, MD            
CyberKnife Centers of Tampa Bay Recruiting
Tampa, Florida, United States, 33615
Contact: Debra Freeman, MD     813-884-7400        
Principal Investigator: Debra Freeman, MD            
South Florida Radiation Oncology, LLC. Recruiting
Wellington, Florida, United States, 33449
Contact: Anthony Addesa, MD     561-795-9845        
Principal Investigator: Kishore Dass, MD            
Principal Investigator: Anthony Addesa, MD            
United States, Nebraska
St. Elizabeth CyberKnife Center Recruiting
Lincoln, Nebraska, United States, 68510
Contact: A Akins     402-219-8000        
Principal Investigator: Kevin Yiee, MD            
United States, New York
CyberKnife Center of New York Recruiting
Johnson City, New York, United States, 13790
Contact: Martha Nelson     607-763-6666        
Principal Investigator: Rashid Haq, MD            
United States, Ohio
First Dayton Cancer Care Recruiting
Dayton, Ohio, United States, 45420
Contact: Edward Hughes, MD     937-293-2273        
Contact: Jo Hayes            
Principal Investigator: Edward Hughes, MD            
United States, Texas
St. Luke's Episcopal Hospital Recruiting
Houston, Texas, United States, 77030
Contact: Catalina Gutierrez     832-355-7226     cgutierrez@sleh.com    
Principal Investigator: L. Steven Carpenter, MD            
Sponsors and Collaborators
Florida Robotic Radiosurgery Association
Investigators
Principal Investigator: Mark L. Perman, MD South Florida Radiation Oncology, LLC.
  More Information

No publications provided

Responsible Party: Florida Robotic Radiosurgery Association
ClinicalTrials.gov Identifier: NCT01226004     History of Changes
Other Study ID Numbers: FRRA01
Study First Received: October 20, 2010
Last Updated: March 28, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Florida Robotic Radiosurgery Association:
radiosurgery
prostate
cancer
early
intermediate
CyberKnife

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on June 18, 2013